VTGN analyst estimates

Vistagen Therapeutics (VTGN) analyst ratings, the average price target and its range, and every firm's latest call.

VTGN analyst ratings and price targets

DateFirmCallTarget
Dec 17, 2025Stifel NicolausVistagen downgraded to Hold at Stifel after PALISADE-3 study disappoints$1.00
Dec 17, 2025JefferiesJefferies Downgrades VistaGen Therapeutics (VTGN) to Hold$0.90
Nov 17, 2025Stifel NicolausStifel Reiterates Buy Rating on VistaGen Therapeutics (VTGN)$12.00
Jul 22, 2022JefferiesVistaGen Therapeutics downgraded to Hold from Buy at Jefferies$0.20